
Journal of the American Chemical Society p. 546 - 551 (1988)
Update date:2022-09-26
Topics:
Bellucci, Giuseppe
Bianchini, Roberto
Chiappe, Cinzia
Marioni, Franco
Spagna, Riccardo
It has been shown that the bromonium-bromide ion-pair intermediate generated from the reaction of trans-10-bromo-10,11-dihydro-11-hydroxy-5H-dibenzazepine-5-carbonyl chloride (3) with HBr in 1,2-dichloroethane, chloroform, or carbon tetrachloride can either collapse to trans-10,11-dibromo-10,11-dihydro-5H-dibenz/b,f/azepine-5-carbonyl chloride (4) or release molecular Br2 to give 5H-dibenzazepine-5-carbonyl chloride (1).The ratio of these two products changes from ca. 7:3 in 1,2-dichloroethane to ca. 7:3 in carbon tetrachloride.Olefin 1 is similarly obtained in 50 percent yield when bromohydrin 3 is reacted with BF3.Et2O in chloroform in the presence of resorcinol, which acts as a Br+ scavenger and is transformed into its 4-bromo derivative. 5H-Dibenzazepine-5-carbonyl chloride adds Br2 in 1,2-dichloroethane at 50 deg C according to a third-order rate law with a rate constant (K3=1.9(0.1)E-2 M-2s-1) that is 4 orders of magniture lower with respect to than of the acyclic analogue cis-stilbene and gives only the trans-dibromide 4.The latter is debrominated easily to olefin 1 at 25 deg C in dimethylformamide without the addition of any specific reagent or slowly in acetonitrile in the presence of cis-stilbene as a Br2 scaverger, through the same bromonium-bromide ion-couple intermediate involved in the reaction of bromohydrin 3 with HBr.The easy reversion of this intermediate back to olefin and Br2 has been rationalized on the basis of the structural parameters obtained by X-ray diffraction of dibromide 4, showing a highly strained C(10)-C(11)-C(11a) internal angle of 121 deg and strongly unequivalent bromine atoms, with a rather longer Br-C(11) bond.
View MoreContact:+86-13914766747
Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
Xiamen XM-Innovation Chemical Co., Ltd
Contact:+86-592-3216205
Address:Unit Q, 11/F, No.1 Office Building, Wuyuan Bay Business Center, Huli District, Xiamen City, Fujian Province, P.R.C
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Shandong Xinhua Pharmaceutical Co.,Ltd
website:http://www.xhzy.com
Contact:+86-533-2196801
Address:1 lutai road,zhangdian dis,Zibo City
Doi:10.1016/S0040-4039(99)01322-2
(1999)Doi:10.1016/S0022-328X(00)99500-7
(1983)Doi:10.1016/S0040-4020(01)97962-1
(1981)Doi:10.1002/zaac.200400049
(2004)Doi:10.1016/S0022-328X(00)82703-5
(1982)Doi:10.1039/P19810002258
(1981)